Note 3 - Newco4pharmacy Transaction: Results of Operations Associated with Discontinued Operations Table Text Block (Tables)

12 Months Ended

Dec. 31, 2016

Tables/Schedules

Results of Operations Associated with Discontinued Operations Table Text Block

	For the Year ending December 31, 2015
Net Sales		$       464,786
Cost of sales		220,228
Gross Profit		244,558
Operating Expenses:
Research and development		734,985
Selling, general and administrative		938,799
Total operating expenses		1,673,784
Operating Loss from Discontinued Operations		(1,429,226)
Other Expense:
Interest expense, net		(775,564)
Disposal on fixed assets		—
Gain (Loss) on debt extinguishment		1,867,428
Net Loss from Discontinued Operations		$     (337,362)
Other Comprehensive Gain Net of Tax:
Foreign currency translation adjustments		24,815
Comprehensive Loss from Discontinued Operations		$     (312,547)